What does Foresite Capital Management V, LLC hold? Q4 2025 13F Holdings & Portfolio

AI Analysis · Q4 2025 · Q4 2025

Foresite Capital Management V, LLC filed its latest 13F-HR for Q4 2025. See the latest holdings and position changes below.

Quarter at a glance — Q4 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q4 2025.

#HoldingValueSharesWeight

ALUMIS INC.

$56M5.8M34.3%

CG Oncology, Inc.

$42M1.0M25.4%

Disc Medicine, Inc.

$24M299K14.4%

Natera, Inc.

$15M67K9.4%

Lyell Immunopharma, Inc.

$15M477K8.9%

Hims & Hers Health, Inc.

$9M273K5.4%

Maze Therapeutics, Inc.

$4M86K2.2%

Filing history loading…